Findings and lessons from the pan-Canadian myeloma priority-setting partnership
Physician’s Weekly – 31/07/2023 – Over the last decade there has been considerable research into the treatment, management, and quality of life of people living with multiple myeloma. However, there has been limited investigation into topics deemed important to patients and caregivers within this community. We conducted a James Lind Alliance Priority Setting Partnership to establish the ‘Top 10 Priorities for Myeloma Research’, informed by patient and public partners.
A research team and steering group were established in 2019 to conduct the myeloma priority-setting partnership. Steering group members included patients, caregivers, and healthcare providers who advised the research team and oversaw the scope of the project, grounded on their lived experience. Following the James Lind Alliance guidelines for the identification and ranking of research questions, we used surveys and a virtual workshop to collect and prioritize questions posed by myeloma patients, caregivers, and healthcare providers across Canada.
The Top 10 list of priorities for myeloma research was finalized at the consensus-building workshop and encompassed questions related to diagnosis, treatment, management, and living well with myeloma. A final participant evaluation survey elicited a positive response.
The myeloma priority setting partnership identified the research priorities of people living with myeloma, caregivers, and healthcare providers to inform clinical research on this disease going forward. This project underscores the importance of patient and public engagement in the identification of research questions, highlighting the concerns of people affected by myeloma to ultimately improve the lives of people living with this disease.
Reference: Bridges, S. et al. Res Involv Engagem 2023;9(60). https://doi.org/10.1186/s40900-023-00476-9
Contributors: Sarah Bridges, Samantha Fowler, Lauren McLaughlin, Marc Robichaud, Barbara Ridgway, Donna Reece, Kevin Song, Lorelei Dalrymple, Robin Sully, Sharon Nason, Suzanne Rowland, Trish MacDonald, William Paine, Adrienne Gulliver, Anthony Reiman
Originally Published By Physician’s Weekly. Reused by Medicom Medical Publishers with permission.
©2023 Physician’s Weekly. All rights reserved. No works may be reproduced without expressed written consent from Physician’s Weekly. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by Physician’s Weekly.
Posted on
Previous Article
« Overweight/obese BMI linked to worse survival in young people with leukemia Next Article
ERS 2023 Highlights Podcast »
« Overweight/obese BMI linked to worse survival in young people with leukemia Next Article
ERS 2023 Highlights Podcast »
Related Articles
April 23, 2024
Second-line therapy for multiple myeloma: Where we are now?
February 20, 2023
CAR-Hematotox score proves useful in relapsed/refractory MM
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com